Printer Friendly
The Free Library
19,585,946 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Akorn, Inc. Announces Second Quarter Earnings Release And Conference Call Information.


BUFFALO GROVE Buffalo Grove

A village of northeast Illinois, a suburb of Chicago. Population: 43,300.
, Ill. -- Akorn, Inc. (AMEX AMEX

See: American Stock Exchange
:AKN AKN King Salmon Airport (Alaska)
AKN Altona-Kaltenkirchen-Neumünster (public transportation system in the north of Hamburg, Germany)
AKN Net Cargo Ship (Auxiliary, Cargo, Net) 
) announced today that its second quarter 2006 earnings release has been scheduled for Wednesday, July 26, 2006, at 4:00 p.m. (Eastern Time). The Company will also publish the release on its website at www.akorn.com. In addition, Arthur S. Przybyl, President and Chief Executive Officer, and Jeffrey A. Whitnell, Chief Financial Officer, will host an earnings conference call Wednesday, July 26th, 2006, beginning at 5:00 p.m. (Eastern Time).
What:     Akorn, Inc. Second Quarter 2006 Earnings Conference Call

When:     Wednesday, July 26, 2006 at 5:00 p.m., Eastern Time

Website:  Live webcast available at www.akorn.com or
          http://www.videonewswire.com/event.asp?id=34645

A replay of the conference call will follow immediately and continue
for 30 days.


About Akorn, Inc.

Akorn, Inc. manufactures and markets sterile specialty pharmaceuticals. Akorn has manufacturing facilities located in Decatur, Illinois
For other uses, see Decatur.
Decatur is the largest city and the county seat of Macon County in the U.S. state of Illinois. The city, known as "The Soybean Capital of the World" was founded in 1836 and is located in Central Illinois along the Sangamon
 and Somerset, New Jersey Somerset is a census-designated place and unincorporated area located at the eastermost section within Franklin Township, in Somerset County, New Jersey. As of the United States 2000 Census, the CDP population was 23,040. Somerset housed one of the first Marconi Wireless Stations.  and markets and distributes an extensive line of hospital and ophthalmic pharmaceuticals. Additional information is available at the Company's website at www.akorn.com.

Materials in this press release may contain information that includes or is based upon forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 within the meaning of the Securities Litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute.

When a person begins a civil lawsuit, the person enters into a process called litigation.
 Reform Act of 1995. Forward-looking statements give our expectations or forecasts of future events. You can identify these statements by the fact that they do not relate strictly to historical or current facts. They use words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe," and other words and terms of similar meaning in connection with a discussion of future operating or financial performance. In particular, these include statements relating to relating to relate prepconcernant

relating to relate prepbezüglich +gen, mit Bezug auf +acc 
 future steps we may take, prospective products, future performance or results of current and anticipated products, sales efforts, expenses, the outcome of contingencies such as legal proceedings All actions that are authorized or sanctioned by law and instituted in a court or a tribunal for the acquisition of rights or the enforcement of remedies. , and financial results.

Any or all of our forward-looking statements here or in other publications may turn out to be wrong. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Many such factors will be important in determining our actual future results. Consequently, no forward-looking statement can be guaranteed. Our actual results may vary materially, and there are not guarantees about the performance of our stock.

Any forward-looking statements represent our expectations or forecasts only as of the date they were made and should not be relied upon as representing our expectations or forecasts as of any subsequent date. We undertake no obligation to correct or update any forward-looking statements, whether as a result of new information, future events or otherwise, even if our expectations or forecasts change. You are advised, however, to consult any further disclosures we make on related subjects in our reports filed with the SEC. In particular, you should read the discussion in the section entitled "Cautionary Statement Regarding Forward-Looking Statements" in our most recent Annual Report on Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
, as it may be updated in subsequent reports filed with the SEC. That discussion covers certain risks, uncertainties and possibly inaccurate assumptions that could cause our actual results to differ materially from expected and historical results. Other factors besides those listed there could also adversely affect our results.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jul 20, 2006
Words:528
Previous Article:IONA Reports Second Quarter Results; Artix Sales Accelerating, Revenue up 128%.
Next Article:Affordable Residential Communities to Hold Second Quarter 2006 Earnings Conference Call.
Topics:



Related Articles
Akorn, Inc. Schedules Third Quarter 2002 Financial Conference Call.
Akorn, Inc. Reports Net Sales of $10.2 Million in 2005 First Quarter With Gross Margin of 33%, Breakeven EBITDA and Positive Cash Flow.
Akorn, Inc. Announces First Quarter Earnings Release And Conference Call Information.
Akorn, Inc. Revises Time of Q1'06 Earnings Release.
Akorn, Inc. Reports First Quarter 2006 Revenues of $30 million, 40% Gross Margin and Diluted Earnings per Share of $0.04.
Akorn, Inc. Reports Second Quarter 2006 Revenues Of $12.5 Million And 40% Gross Margin.
Akorn, Inc. Announces Third Quarter 2006 Earnings Release and Conference Call Information.
Akorn, Inc. Signs Exclusive Distribution Agreement With Massachusetts Biologic Laboratories For Tetanus Diphtheria Vaccine.
Akorn, Inc. Announces First Quarter 2007 Earnings Release and Conference Call Information.
Akorn Reports First Quarter 2007 Financial Results.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles